Overview

A class action lawsuit has been filed against Telix Pharmaceuticals Ltd. (“Telix” or the “Company”) and certain of the Company’s former and current senior executive officers alleging violations of the federal securities laws. Telix American Depositary Shares (“ADS” or “ADSs” trade on the Nasdaq Global Select Market (the “NASDAQ”) under the ticker symbol “TLX”.

The Telix class action lawsuit was brought on behalf of all persons and entities who purchased or otherwise acquired publicly traded Telix securities between February 21, 2025, and August 28, 2025, both dates inclusive, (the “Class Period”).

Telix is a biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies.

The lawsuit alleges that Defendants, throughout the Class Period, made false and/or misleading statements and/or failed to disclose that: (1) Defendants materially overstated the progress Telix had made with regard to prostate cancer therapeutic candidates; (2) Defendants materials overstated the quality of Telix’s supply chain and partners; and (3) as a result, defendants statements about Telix’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

*          *          *

If you purchased or otherwise acquired publicly traded Telix securities between February 21, 2025, and August 28, 2025, both dates inclusive, (the “Class Period”), you may be eligible to serve as lead plaintiff in this lawsuit. If you invested in Telix securities and wish to seek appointment as lead plaintiff, we encourage you to contact DiCello Levitt LLP by submitting your information through the form on this page.

You can also contact DiCello Levitt partner Brian O’Mara by calling (888) 287-9005 or at investors@dicellolevitt.com. 

The deadline to apply to the Court to serve as lead plaintiff in the Telix class action lawsuit is January 9, 2026.